ENSEM Therapeutics
MA - WalthamBiotechnology
Focus: ENSEM Therapeutics is a public-stage biotechnology company specializing in characterizing rare conformational states in drug targets, focusing on rare disease applications. The company operates from Waltham, MA with a discovery-stage platform.
Profile data last refreshed 2d ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About ENSEM Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow ENSEM Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
ETX-636 dose escalation
Advanced Solid TumorsClinical Trials (1)
NCT06993844Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Phase 1/2Help build intelligence for ENSEM Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.